Liver NK Cells Expressing TRAIL Are Toxic against Self Hepatocytes in Mice

Hepatology

Volumn 39, Issue 5, 2004, Pages 1321-1331

  Ochi, Makoto ^a   Ohdan, Hideki ^a   Mitsuta, Hiroshi ^a   Onoe, Takashi ^a   Tokita, Daisuke ^a   Hara, Hidetaka ^a   Ishiyama, Kohei ^a   Zhou, Wendy ^a   Tanaka, Yuka ^a   Asahara, Toshimasa ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAMYCIN A; FAS ANTIBODY; LY 49 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; PERFORIN; POLYCYTIDYLIC ACID; POLYINOSINIC ACID; PROTEIN INHIBITOR; RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE MODEL; IMMUNOLOGICAL TOLERANCE; LIVER CELL; LIVER TOXICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; UPREGULATION;

ANIMALS; ANTIGENS, LY; APOPTOSIS REGULATORY PROTEINS; CELL COMMUNICATION; HEPATOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIVER; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, SCID; SPLEEN; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2342447293     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20204     Document Type: Article

References (49)

1. Yokoyama WM. Natural killer cells. In: Paul EW, ed. Fundamental Immunology. 4th ed. Philadelphia, Pa: Lippincott-Raven; 1999:575-603.
2. Seki S, Habu Y, Kawamura T, Takeda K, Dobashi H, Ohkawa T, Hiraide H. The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol Rev 2000;174:35-46.
3. Goossens PL, Jouin H, Marchal G, Milon G. Isolation and flow cytometric analysis of the free lymphomyeloid cells present in murine liver, J Immunol Methods 1990;132:137-144.
4. Takahashi M, Ogasawara K, Takeda K, Hashimoto W, Sakihara H, Kumagai K, et al. LPS induces NK1.1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. J Immunol 1996;156:2436-2442.
5. Crispe IN, Mehal WZ. Strange brew: T cells in the liver. Immunol Today 1996;17:522-525.
6. Minagawa M, Oya H, Yamamoto S, Shimizu T, Bannai M, Kawamura H, et al. Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation. HEPATOLOGY 2000;31:907-915.
7. Takeda K, Seki S, Ogasawara K, Anzai R, Hashimoto W, Sugiura K, et al. Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J Immunol 1996;156:3366-3373.
8. Liu ZX, Govindarajan S, Okamoto S, Dennert G. NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J Immunol 2000;164:6480-6486.
9. Nishikage T, Seki S, Toyabe S, Abo T, Kagata Y, Iwai T, et al. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis. J Hepatol 1999;31:18-26.
10. Nakagawa R, Nagafune I, Tazunoki Y, Ehara H, Tomura H, Iijima R, et al. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice. J Immunol 2001;166:6578-6584.
11. Lanier LL. NK cell receptors. Annu Rev Immunol 1998;16:359 -393.
12. Yokoyama WM. Natural killer cell receptors. Curr Opin Immunol 1998;10:298-305.
13. Skoskiewicz MJ, Colvin RB, Schneeberger EE, Russell PS. Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interfeton. J Exp Med 1985;162:1645-1664.
14. Kagi D, Seiler P, Pavlovic J, Ledermann B, Burki K, Zinkernagel RM, et al. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol 1995;25:3256-3262.
15. Schneider P, Holler N, Bodmer JL, Hahne M, Frei K, Fontana A. et al. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with down regulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 1998;187:1205-1213.
16. Kashii Y, Giorda R, Herberman RB, Whiteside TL, Vujanovic NL. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J Immunol 1999;163:5358-5366.
17. Smyth MJ, Thia KY, Street SE, MacGregor D, Godfrey DI, Trapani JA. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med 2000;192:755-760.
18. Street SE, Cretney E, Smyth MJ. Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. Blood 2001;97:192-197.
19. Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med 1998;188:2375-2380.
20. Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, et al. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J Immunol 1999;163:1906-1913.
21. Smyth MJ, Cretney E, Takeda K, Wiltrout RH, Sedger LM, Kayagaki N, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med 2001;193:661-670.
22. Bouwens L, Remels L, Baekeland M, Van Bossuyt H, Wisse E. Large granular lymphocytes or "pit cells" from rat liver: isolation, ultrastructural characterization and natural killer activity. Eur J Immunol 1987;17:37-42.
23. Seglen PO. Preparation of isolated rat liver cells. Methods Cell 1976;13:29-83.
24. Tateno C, Takai-Kajihara K, Yamasaki C, Sato H, Yoshizato K. Heterogeneity of growth potential of adult rat hepatocytes in vitro. HEPATOLOGY 2000;31:65-74.
25. Ostrowska A, Karrer FM, Bilir BM. Histological identification of purified and cryopreserved allogeneic hepatocytes following transplantation in a murine model without host immunosuppression. Transpl Int 1999;12:188-194.
26. Djeu JY, Heinbaugh JA, Holden HT, Herberman RB. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol 1979;122:175-181.
27. Wiltrout RH, Mathieson BJ, Talmadge JE, Reynolds CW, Zhang SR, Herberman RB, et al. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. J Exp Med 1984;160:1431-1449.
28. Vujanovic NL, Polimeno L, Azzarone A, Francavilla A, Chambers WH, Starzl TE, et al. Changes of liver-resident NK cells during liver regeneration in rats. J Immunol 1995;154:6324-6338.
29. Vanderkerken K, Bouwens L, Wisse E. Characterization of a phenotypically and functionally distinct subset of large granular lymphocytes (pit cells) in rat liver sinusoids. HEPATOLOGY 1990;12:70-75.
30. Luo D, Vanderkerken K, Chen MC, Vermijlen D, Asosingh K, Willems E, et al. Rat hepatic natural killer cells (pit cells) express mRNA and protein similar to in vitro interleukin-2 activated spleen natural killer cells. Cell Immunol 2001;210:41-48.
31. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999;5:157-163.
32. Tanaka S, Sugimachi K, Shirabe K, Shimada M, Wands JR. Expression and antitumor effects of TRAIL in human cholangiocarcinoma. HEPATOLOGY 2000;32:523-527.
33. Yamanaka T, Shiraki K, Sugimoto K, Ito T, Fujikawa K, Ito M, et al. Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines. HEPATOLOGY 2000;32:482-490.
34. Gores GJ, Kaufmann SH. Is TRAIL hepatotoxic? HEPATOLOGY 2001;34:3-6.
35. Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR, et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 2000;6:564-567.
36. Ichikawa K, Liu W, Zhao L, Wang Z, Liu D, Ohtsuka T, et al. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med 2001;7:954-960.
37. Daniels BF, Karlhofer FM, Seaman WE, Yokoyama WM. A natural killer cell receptor specific for a major histocompatibility complex class I molecule. J Exp Med 1994;180:687-692.
38. Stoneman ER, Bennett M, An J, Chesnut KA, Wakeland EK, Scheerer JB, et al. Cloning and characterization of 5E6(Ly-49C), a receptor molecule expressed on a subset of murine natural killer cells. J Exp Med 1995;182:305-313.
39. Brennan J, Lemieux S, Freeman JD, Mager DL, Takei F. Heterogeneity among Ly-49C natural killer (NK) cells: characterization of highly related receptors with differing functions and expression patterns. J Exp Med 1996;184:2085-2090.
40. Hanke T, Takizawa H, McMahon CW, Busch DH, Pamer EG, Miller JD, et al. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 1999;11:67-77.
41. Mason LH, Ortaldo JR, Young HA, Kumar V, Bennett M, Anderson SK. Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2). J Exp Med 1995;182:293-303.
42. Michaelsson J, Achour A, Salcedo M, Kase-Sjostrom A, Sundback J, Harris RA, et al. Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers. Eur J Immunol 2000;30:300-307.
43. Held W, Raulet DH. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J Exp Med 1997;185:2079-2088.
44. Brawand P, Lemonnier FA, MacDonald HR, Cerottini JC, Held W. Transgenic expression of Ly49A on T cells impairs a specific antitumor response. J Immunol 2000;165:1871-1876.
45. Fahlen L, Lendahl U, Sentman CL. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells. J Immunol 2001;166:6585-6592.
46. Ohashi K, Park F, Kay MA. Hepatocyte transplantation: clinical and experimental application. J Mol Med 2001;79:617-630.
47. Yoshida Y, Tokusashi Y, Lee GH, Ogawa K. Intrahepatic transplantation of normal hepatocytes prevents Wilson's disease in Long-Evans cinnamon rats. Gastroenterology 1996;111:1654-1660.
48. Gupta S, Chowdhary JR. Hepatocyte transplantation: back to the future. HEPATOLOGY 1992;15:156-162.
49. Gupta S, Rajvanshi P, Sokhi R, Slehria S, Yam A, Kerr A, et al. Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium. HEPATOLOGY 1999;29:509-519.